With nearly 18,000 subscribers worldwide, Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
在全球拥有近18000个订户,癌症研究是基础和临床肿瘤学领域最受重视和认可的期刊之一。它旨在为医生提供癌症领域当前进展状况的全面资源,以及有效决策所需的可靠信息的广泛背景。除了发表具有重要意义的原始论文外,它还发表评论、论文、争议的专门介绍、对新技术及其在具体实验室问题上的应用的考虑、公共问题的讨论、关于主要主题的小系列、新的和实验性药物和疗法,以及致编辑部的无创意信函。《华尔街日报》的一个独特之处是其部门化的编辑部分,报告了30多个学科类别,涵盖了广泛的专门领域,这些领域共同构成了肿瘤学领域。由主要的医生和研究科学家编辑,这些部分使癌症调查成为临床医生寻求理解这个领域中有时大量信息的主要资源。除了同行评审的临床研究外,该杂志还以翻译研究为特色,弥合实验室和临床之间的差距。
期刊ISSN
|
0735-7907 |
最新的影响因子
|
2.4 |
最新CiteScore值
|
2.24 |
最新自引率
|
2.60% |
期刊官方网址
|
http://www.tandfonline.com/toc/icnv20/current#.V4hzokz9cSQ |
期刊投稿网址
|
https://mc.manuscriptcentral.com/lcnv |
通讯地址
|
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106 |
偏重的研究方向(学科)
|
医学-肿瘤学 |
出版周期
|
Bimonthly |
平均审稿速度
|
平均8.5月 |
出版年份
|
1983 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
JCR学科排名
医学
ONCOLOGY(肿瘤学) 4区
171/223
|
|||||||
最新的影响因子
|
2.4 | |||||||
最新公布的期刊年发文量 |
|
|||||||
总被引频次 | 2473 | |||||||
特征因子 | 0.002260 | |||||||
影响因子趋势图 |
2007年以来影响因子趋势图(整体平稳趋势)
|
最新CiteScore值
|
2.24
=
引文计数(2018)
文献(2015-2017)
=
452次引用
202篇文献
|
||||||||||
文献总数(2014-2016) | 202 | ||||||||||
被引用比率
|
73% | ||||||||||
SJR
|
0.858 | ||||||||||
SNIP
|
0.689 | ||||||||||
CiteScore排名
|
|
||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
||||||||||
scopus涵盖范围 |
scopus趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
NEURO-ONCOLOGY | 15.9 |
JOURNAL OF NEURO-ONCOLOGY | 3.9 |
OncoImmunology | 7.2 |
JOURNAL OF IMMUNOTHERAPY | 3.9 |
Cancer Immunology Research | 10.1 |
Infectious Agents and Cancer | 3.7 |
CANCER IMMUNOLOGY IMMUNOTHERAPY | 5.8 |
INTEGRATIVE CANCER THERAPIES | 2.9 |
Hormones & Cancer | 3 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
Infectious Agents and Cancer | 3.7 |
Frontiers of Medicine | 8.1 |
Molecular Medicine Reports | 3.4 |
Breast Care | 2.1 |
Breast Cancer | 4 |
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 0.4 |
FOLIA BIOLOGICA | 0.6 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2 |
Onkologe | 0.234 |
分享者 | 点评内容 |
发表日期:2019-01-21 |
研究方向:医学 肿瘤学
录用情况:已投结果未知
审稿时间:4个月内
这几年影响因子降低不少,希望之后能再升回来。
(0)
|
发表日期:2016-10-26 |
研究方向:肿瘤
近三年影响影响因子:
2015年:2.231
2014年:2.218
2013年:2.06
杂志速度特别慢,我投稿三个月后看没反应,发邮件询问之后,要求我推荐几个审稿人,搞半天还没开始审稿!
(0)
|
发表日期:2014-07-08 |
研究方向:肿瘤
审稿时间:6个月内
接收率: 中等(50%命中)
投稿后都显示under review两个月了,询问之后回复说还没找到审稿人?
(0)
|